As monsoon rains sweep across India, rural communities face a dangerous seasonal surge in snakebite incidents-an often overlooked but critical public health emergency. BSV, a Mankind Group Company and a trusted leader in high-quality anti-snake venom (ASV) for over two decades, has intensified its efforts by rolling out a comprehensive ‘4A’ Framework to address the challenge nationwide.
The framework focuses on four critical pillars: Awareness, Access, Availability, and Action, aimed at improving prevention, timely intervention, and clinical outcomes in snakebite cases. BSV’s priority remains driving awareness by dispelling long-standing myths and educating rural populations on evidence-based snakebite first aid and treatment. Ensuring access to the nearest healthcare facility and strengthening the availability of quality-assured ASV across rural and semi-urban regions are vital to effective management. Most importantly, action administering the right treatment at the right time can significantly reduce mortality and prevent severe complications such as neurotoxicity (paralysis), coagulopathy, acute kidney injury, multi-organ dysfunction, and death
Sivani Sarma Deka, COO, India Business, BSV, said, “As a market leader in anti-snake venom, BSV has consistently led the way in delivering scientifically advanced, high-quality, and effective treatments for snakebite management. The Ministry of Health’s directive to classify snakebite as a notifiable disease is a landmark step toward addressing data fragmentation, optimizing ASV distribution, and building a robust nationwide surveillance system. However, achieving the goal of halving snakebite-related deaths by 2030 will require strong on-ground execution. This includes intensified community awareness, seamless last-mile access to treatment, upskilling rural healthcare providers, and empowering communities with correct first-aid knowledge to eliminate delays in care. As a responsible organization, we remain committed to enhancing both community education and continuous medical training for healthcare professionals, ensuring adherence to government-prescribed Standard Treatment Guidelines (STGs).
Adding to this, Dr. S Senthilkumaran, Medical Director, Manian Medical Centre, Erode said, “Snakebite continues to be a major public health concern in India. According to the World Health Organization, nearly 58,000 deaths occur annually due to snakebites in the country accounting for almost half of the global burden. Every minute of delay significantly reduces a victim’s chance of recovery. Bridging the gap between field-level identification and rapid clinical intervention is critical. By combining community education to dispel harmful myths with a strong commitment to ensuring last-mile access to life-saving treatment, we can prevent severe medical complications and save thousands of lives.”
Addressing India’s snakebite burden requires a concerted, multi-stakeholder approach involving communities, healthcare providers, policymakers, and industry leaders. Strengthening rural healthcare infrastructure, improving surveillance systems, and ensuring uninterrupted ASV supply are key to sustained impact. Ultimately, defeating the snakebite crisis in India and achieving the global target of halving mortality by 2030 will depend on effectively bridging the gap between rural exposure and clinical care. Ensuring that every snakebite victim receives timely, appropriate, and life-saving treatment must remain the central focus of all interventions.
.JPG)
0 Comments